BIOQ (Bioqual) Shares Outstanding (EOP): 0.89 Mil (As of Nov. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOQ Bioqual Inc BIOQ
54 GF Score
Price $33.00
! 4 Warning Signs
View Full Analysis

What is Bioqual Shares Outstanding (EOP)?

Bioqual BIOQ 54 Shares Outstanding (EOP) is 0.89 Mil as of Nov. 2025. GuruFocus rates BIOQ with a GF Score™ of 54/100. The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Bioqual's shares outstanding for the quarter that ended in Nov. 2025 was 0.89 Mil.

Bioqual's quarterly shares outstanding stayed the same from Aug. 2025 (0.89 Mil) to Nov. 2025 (0.89 Mil).

Bioqual's annual shares outstanding increased from May. 2017 (0.89 Mil) to May. 2018 (0.89 Mil). It means Bioqual issued new shares from May. 2017 to May. 2018 .


Bioqual  (OTCPK:BIOQ) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Bioqual Shares Outstanding (EOP) Related Terms


Bioqual Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Bioqual's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioqual Shares Outstanding (EOP) Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 0.90 0.90 0.89 0.89

Bioqual Quarterly Data
Aug06 Nov06 Feb07 May07 Nov09 Feb10 May10 Aug10 Nov10 Feb11 May11 Aug11 May17 May18 Aug22 Aug23 Aug24 Nov24 Aug25 Nov25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.89 0.89 0.89 0.89

BIOQ vs ADVB, QUCY, MDXH: Shares Outstanding (EOP) Comparison

For the Diagnostics & Research subindustry, Bioqual's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioqual Shares Outstanding (EOP) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Bioqual's Shares Outstanding (EOP) falls into.


BIOQ
54GF Score
Bioqual Inc BIOQ
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioqual Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 0.89 Mil mean?
Bioqual (BIOQ) has a Shares Outstanding (EOP) of 0.89 Mil as of Nov. 2025. The total shares a company has outstanding, at period-end. View historical data on Bioqual and its competitors.
Is Bioqual's Shares Outstanding (EOP) too high?
Bioqual's current Shares Outstanding (EOP) is 0.89 Mil. Overall, Bioqual has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Bioqual's Shares Outstanding (EOP) compare to ADVB and QUCY?
Bioqual's Shares Outstanding (EOP) of 0.89 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Diagnostics & Research company?
A good Shares Outstanding (EOP) depends on the Medical Diagnostics & Research industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Bioqual and its competitors. Bioqual's current Shares Outstanding (EOP) is 0.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioqual stock overvalued right now?
Bioqual (BIOQ) has a current Shares Outstanding (EOP) of 0.89 Mil. The current Shares Outstanding (EOP) is 0.89 Mil. Bioqual's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Bioqual (BIOQ), the current Shares Outstanding (EOP) is 0.89 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioqual Business Description

Address 9620 Medical Center Drive, Suite 310, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
54GF Score

Get the complete analysis for BIOQ

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.00
Price